 |
| Siegfried AG sells 100% of Siegfried Biologics (Germany) to Avestha Biotherapeutics and Research in India. |
 |
ICFG Zurich - AVaccani&Partners
| Target Company Name | Siegfried Biologics GmbH |
|---|---|
| Deal Types |
|
| Target Country | Germany |
| Buyer Name / MBO Team / MBI Team | Avestha Biotherapeutics and Research Pvt. Ltd. |
| Buyer Country | Asia |
| Transaction Description | Siegfried AG (Zofingen, Switzerland), a publicly quoted chemical / pharmaceutical company (SWX: SFZN) sells 100% of Siegfried Biologics GmbH (Berlin, Germany), to Avestha Biotherapeutics and Research Pvt. Ltd. (Bangalore, India), a leading Indian biotech development company. A.Vaccani&Partners acted as exclusive M&A advisors to Siegfried AG in all phases of the sales process. |
| Industry Sectors |
|
| ICFG Office | Zurich, Switzerland |
| ICFG Advisory | ICFG Zurich - AVaccani&Partners |